About the journal (scope)
Klinisk Biokemi i Norden (KBN) is the journal of the Nordic Federation of Clinical Chemistry (NFKK), distributed to members of the Nordic national societies of clinical chemistry. KBN provides a platform for sharing knowledge, experience, and perspectives within clinical biochemistry and laboratory medicine. The journal is published quarterly and has a broad and practical scope, with a more informal and accessible style than traditional scientific journals. By publishing in KBN, authors contribute to knowledge sharing across the Nordic region and may be eligible for the Hellsing Award for best article of the year. KBN covers a broad range of topics relevant to clinical biochemistry and laboratory medicine, accepting the following types of contributions:
- Practical aspects of laboratory work
- Clinical and analytical topics of shared interest
- Organization of laboratory services, research, and education
- Experiences and perspectives from everyday laboratory practice (e.g. case stories)
- Summaries of PhD theses and dissertations
- Educational articles and training material
- Presentations of Nordic research groups and initiatives
- Reports from meetings, working groups, and committees
- Debate articles and letters to the editor
We particularly encourage submissions from early-career professionals. Articles are not routinely externally peer reviewed. All manuscripts are assessed by the editorial board, and in some cases external reviewers may be consulted.
Language
Manuscripts may be submitted in Danish, English, Norwegian, or Swedish.
Manuscript requirements
- Include a short summary (3-4 sentences) after the title
- Use subheadings to improve readability
- Write clearly and concisely, with emphasis on practical relevance
Author information
Author information should include full names and affiliations, email of the corresponding author, and portrait photos of all authors.
Figures and tables
- Submit as separate files (JPG preferred)
- If the figures were created in Excel, we would appreciate receiving the Excel files
- Indicate placement in the text
- Provide captions
- Ensure permission if previously published
References
References should be limited to a maximum of 20, formatted in Vancouver style, and numbered according to the order in which they appear in the text. If more than three authors, list the first three followed by et al. If more than 20 references, select the 20 most important for the journal. The remaining references should be numbered in the order in which they appear in the text; readers are requested to contact the author for further information.
Examples of References
- Journal article with up to three authors: Vermeersch P, Mariën G, Bossuyt X. A case of pseudoparaproteinemia on capillary zone electrophoresis caused by geloplasma. Clin Chem 2006;52:2309-11.
- Journal article with more than three authors: Fiechtner M, Ramp J, England B, et al. Affinity binding assay of glycohemoglobin by two-dimensional centrifugation referenced to hemoglobin Alc. Clin Chem 1992;38:2372–9.
- Abstract: Hortin GL, King C, Kopp J. Quantification of rhesus monkey albumin with assays for human microalbumin [Abstract]. Clin Chem 2000;46:A140-1.
- Book chapters: Rifai N, Warnick GR. Lipids, lipoproteins, apolipoproteins, and other cardiovascular risk factors. In: Burtis CA, Ashwood ER, Bruns DE, eds. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. 4th Ed. St. Louis: Elsevier Saunders 2006:903-81.
- PhD theses: Haughton MA. Immunonephelometric measurement of vitamin D binding protein [MAppSci thesis]. Sydney, Australia: University of Technology, 1989:87pp.
- Online published article ahead of print: Milbury CA, Li J, Makrigiorgos GM. PCR-based methods for the enrichment of minority alleles and mutations. [Epub ahead of print] Clin Chem February 6, 2009 as doi:10.1373/clinchem.2008.113035.
- Supplement: Castelli WP. Lipids, risk factors and ischaemic heart disease. Atherosclerosis 1996;124 Suppl:S1-9.
- Internet source: American Association for Clinical Chemistry. AACC continuing education. http://www.aacc.org/development/ce/pages/default.aspx# (Accessed March 2012).
Special article types
PhD thesis summaries should consist of maximum 1250 words, up to 4 figures, and no more than 10 references.
Ethics and Transparency
Authors must disclose any conflicts of interest and funding sources if relevant. Authors are responsible for ensuring scientific accuracy and adherence to ethical standards.
Use of artificial intelligence (AI)
KBN follows a pragmatic and transparent approach to the use of AI tools:
- Manuscripts must be written by humans; AI tools cannot be listed as authors
- AI tools may be used for language editing, structuring, or translation
- Authors are fully responsible for the accuracy, integrity, and originality of the content
If AI tools have been used, this must be disclosed at submission and briefly described (e.g. tool and purpose of use).
Important limitations: AI must not be used to generate data or fabricate references, and all AI-generated content must be critically reviewed by the authors.
Submission
Please submit manuscripts to your national editor, including all figures, portrait photos and supplementary material.